En direct

Le Centre de Recherche en Cancérologie de Marseille fête ses 50 ans ! -

Dec 2009 Haematologica

TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia.

Auteurs

Kosmider O, Gelsi-Boyer V, Ciudad M, Racoeur C, Jooste V, Vey N, Quesnel B, Fenaux P, Bastie JN, Beyne-Rauzy O, Stamatoulas A, Dreyfus F, Ifrah N, de Botton S, Vainchenker W, Birnbaum D, Fontenay M, Solary E,

Résumé

Acquired somatic deletions and loss-of-function mutations in one or several codons of the TET2 (Ten-Eleven Translocation-2) gene were recently identified in hematopoietic cells from patients with myeloid malignancies, including myeloproliferative disorders and myelodys-plastic syndromes. The present study was designed to determine the prevalence of TET2 gene alterations in chronic myelomonocytic leukemias.

Lire l‘article